Wait, we have a special offer for you! ✋

Get your exclusive discount now

YES, get the discount! No, I'd pay the full price
POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033

POCT (Point of Care Testing) Cardiac Disease Market 2024 – By Type (Digital Apps (Healthcare Solutions), Small Specimen Devices), By End User (Hospitals, Diagnostic Laboratories, Other End Users), And By Region, Opportunities And Strategies – Global Forecast To 2033

POCT (Point of Care Testing) Cardiac Disease Global Market Opportunities And Strategies To 2033

Starting Price : $5000.00 $3500.00 | Pages : 284 | Published : November 2024 | | Format : pdf

Purchase Options
Request a Sample
Request For Discount
Customise Your Report
Item added to cart!
Request For Proposal
Request For Regional Data

Need assistance or more information before the purchase?

Enquire Before Buying

Proud Members Of

checkslacipN checkaoirsN checkscipN
Description Table Of Contents Tables & Figures Market Insights Related Reports

POCT (Point of Care Testing) Cardiac Disease Market Definition

Point-of-care testing (POCT) for cardiac disease refers to diagnostic tests performed near or at the site of patient care allowing for rapid results without the need for centralized laboratory testing. These tests are designed to detect and monitor various cardiac conditions including acute coronary syndromes heart failure and other cardiovascular disorders.

The POCT (point of care testing) cardiac disease market consists of sales by entities (organizations sole traders and partnerships) of POCT (point of care testing) cardiac disease systems solutions and services that play a critical role in emergency and urgent care settings where timely decision-making can significantly impact patient outcomes. The primary users of these tests include healthcare professionals such as doctors nurses and paramedics who utilize them to quickly assess cardiac biomarkers such as troponins and natriuretic peptides to aid in diagnosing heart attacks or monitoring heart function.

Book your 30 minutes free consultation with our research experts

Contact Us

POCT (Point of Care Testing) Cardiac Disease Market Size

The global POCT (point of care testing) cardiac disease market reached a value of nearly $1792.88 million in 2023 having grown at a compound annual growth rate (CAGR) of 6.11% since 2018. The market is expected to grow from $1792.88 million in 2023 to $2648.85 million in 2028 at a rate of 8.12%. The market is then expected to grow at a CAGR of 6.60% from 2028 and reach $3645.65 million in 2033.  

Growth in the historic period resulted from the expansion of healthcare infrastructure increasing adoption of portable and wearable devices and growing demand for home healthcare. Factors that negatively affected growth in the historic period include low healthcare access in developing countries and economic uncertainties or downturns.

Going forward the rising healthcare expenditure globally increasing aging population worldwide rising incidence of cardiovascular diseases favorable government initiatives and increased patient awareness about heart health will drive the growth. Factor that could hinder the growth of the POCT (point of care testing) cardiac disease market in the future include a lack of trained healthcare professionals.  

POCT (Point of Care Testing) Cardiac Disease Market Drivers

The key drivers of the POCT (point of care testing) cardiac disease market include:

Rising Healthcare Expenditure Globally

Rising healthcare expenditures globally are expected to help the growth of the POCT (point of care testing) cardiac disease market going forward. Increased healthcare spending typically results in enhanced infrastructure such as the expansion of diagnostic facilities and the adoption of advanced medical technologies. This environment facilitates the broader implementation of POCT devices which can be effectively used across diverse healthcare settings including hospitals and outpatient clinics. For instance according to the economic forecast from the Office for Budget Responsibility (OBR) and Treasury planned health spending in the UK is expected to rise to £192 billion ($244.43 billion) in 2024/25 from £182 billion ($231.70 billion) in 2022/23.  Additionally according to the National Health Expenditures Accounts (NHEA) by KFF a US-based independent source for health policy research polling and journalism health spending in the USA is expected to rise by 5% from 2023 to 2024 reaching $4.9 trillion. Coverage for new treatments will vary among payers and health plans. By 2030 out-of-pocket spending on retail prescription drugs is projected to total $48.1 billion.  Therefore rising healthcare expenditure globally will drive the growth of the POCT (point of care testing) cardiac disease market in the forecast period.

POCT (Point of Care Testing) Cardiac Disease Market Restraints

The key restraints on the POCT (point of care testing) cardiac disease market include:

Lack Of Trained Healthcare Professionals

The lack of trained healthcare professionals is expected to restrict the growth of the POCT (point of care testing) cardiac disease market going forward. POCT devices are intended to deliver swift diagnostic results directly at the point of care. However their effectiveness is contingent upon correct operation and interpretation by trained professionals. Without a sufficient number of skilled personnel these devices cannot reach their full potential resulting in underutilization. For instance according to the Global Strategy on Human Resources for Health: Workforce 2030 published by the World Health Organization (WHO) there is an anticipated shortfall of 10 million healthcare workers globally by 2030 from 65 million in 2020 mainly in low- and middle-income nations.  Additionally according to the American Hospital Association (AHA) a US-based national organization representing hospitals and health care networks there will be a shortage of up to 124000 physicians by 2033 along with a demand for at least 200000 nurses annually to meet increasing needs. Further a study anticipates that based on current workforce trends over 6.5 million healthcare professionals will exit their roles by 2026 with only 1.9 million replacements anticipated resulting in a national shortage exceeding 4 million workers.  Therefore the lack of trained healthcare professionals may hinder the growth of the POCT (point of care testing) cardiac disease market.

POCT (Point of Care Testing) Cardiac Disease Market Trends

Major trends shaping the POCT (point of care testing) cardiac disease market include:

Increase In Approvals Of Point-Of-Care Test That Deliver Fast Cardiac Troponin Results

Major companies operating in the POCT (point of care testing) cardiac disease market are focusing on point-of-care tests that delivers fast cardiac troponin results. This represents a substantial enhancement compared to traditional laboratory tests which typically require an hour or more to deliver results. For instance in May 2024 Polymedco a US-based laboratory equipment supplier received Food and Drug Administration (FDA) 510(k) clearance for its Pathfast high-sensitivity cardiac troponin I (hs-cTnI-II) assay. This approval establishes it as the first point-of-care test for hs-cTn in the United States. The Pathfast test delivers rapid results for diagnosing myocardial infarction in just 17 minutes using whole blood or plasma samples significantly faster than traditional lab tests which typically take an hour or more. The Pathfast platform is designed to enhance patient care by enabling healthcare providers to make faster diagnostic decisions in emergency settings ultimately improving treatment outcomes for patients suspected of having a heart attack.

Launch Of New Point-Of-Care Tests For Heart Failure

Companies operating in POCT (point of care testing) cardiac disease are launching new point-of-care tests for heart failure which ensures that the test meets the needs of a substantial patient demographic and helps allocate resources effectively to those who need them most. For instance in April 2024 F. Hoffmann-La Roche AG a global healthcare leader based in Switzerland introduced a new POC test for heart failure in India specifically tailored for patients with diabetes. The NT-proBNP test is designed to support early screening for cardiovascular conditions including heart failure in individuals with type 2 diabetes. This test operates on the Cobas h 232 system which enables rapid testing and delivers immediate results in clinical environments. This advancement is pivotal in identifying patients at risk of heart failure earlier thereby allowing for timely intervention and improved patient care.

Opportunities And Recommendations In The POCT (Point of Care Testing) Cardiac Disease Market

Opportunities – The top opportunities in the POCT (point of care testing) cardiac disease market segmented by type will arise in the small specimen devices segment which will gain $499.34 million of global annual sales by 2028. The top opportunities in the POCT (point of care testing) cardiac disease market segmented by end-user will arise in the hospitals segment which will gain $466.07 million of global annual sales by 2028. The POCT (point of care testing) cardiac disease market size will gain the most in the USA at $251.59 million.

Recommendations- To take advantage of the opportunities The Business Research Company recommends the POCT (point of care testing) cardiac disease companies to focus on rapid testing innovations focus on targeted heart failure testing focus on comprehensive testing solutions focus on digital healthcare solutions expand in emerging markets focus on strategic mergers and acquisitions focus on competitive pricing strategies focus on targeted marketing campaigns focus on educational initiatives and focus on other end-users segment.

POCT (Point of Care Testing) Cardiac Disease Market Segmentation

The POCT (point of care testing) cardiac disease market is segmented by type and by end-user.

By Type –
The POCT (point of care testing) cardiac disease market is segmented by type into:
    • a) Digital Apps (Healthcare Solutions)
    • b) Small Specimen Devices
The small specimen devices market was the largest segment of the POCT (point of care testing) cardiac disease market segmented by type accounting for 69.78% or $306.09 million of the total in 2023. Going forward the digital apps (healthcare solutions) segment is expected to be the fastest growing segment in the POCT (point of care testing) cardiac disease market segmented by type at a CAGR of 12.37% during 2023-2028.

By End User –
The POCT (point of care testing) cardiac disease market is segmented by end user into:
    • a) Hospitals
    • b) Diagnostic Laboratories
    • c) Other End-Users
The hospitals market was the largest segment of the POCT (point of care testing) cardiac disease market segmented by end-user accounting for 51.98% or $228.03 million of the total in 2023. Going forward the other end-users segment is expected to be the fastest growing segment in the POCT (point of care testing) cardiac disease market segmented by end-user at a CAGR of 11.97% during 2023-2028.

By Geography - The POCT (point of care testing) cardiac disease market is segmented by geography into:
      o Asia Pacific
      • • China
      • • India
      • • Japan
      • • Australia
      • • Indonesia
      • • South Korea
      o North America
      • • USA
      • • Canada
      o South America
      • • Brazil
      o Western Europe
      • • France
      • • Germany
      • • UK
      • • Italy
      • • Spain
      o Eastern Europe
      • • Russia
      o Middle East
      o Africa
North America was the largest region in the POCT (point of care testing) cardiac disease market accounting for 41.74% or $748.28 million of the total in 2023. It was followed by Asia-Pacific Western Europe and then the other regions. Going forward the fastest-growing regions in the POCT (point of care testing) cardiac disease market will be Asia-Pacific and Africa where growth will be at CAGRs of 10.38% and 9.97% respectively. These will be followed by the Middle East and South America where the markets are expected to grow at CAGRs of 9.66% and 8.84% respectively.

POCT (Point of Care Testing) Cardiac Disease Market Competitive Landscape

Major Competitors are:

  • Wondfo Biotech Co. Ltd.
  • Siemens Healthineers AG
  • QuidelOrtho Corporation
  • F. Hoffmann-La Roche Ltd.
  • Abbott Laboratories

    • Other Competitors Include:

  • OraSure Technologies Inc.
  • Hologic Inc.
  • Thermo Fisher Scientific Inc.
  • SARSTEDT AG & Co. KG
  • Nova Biomedical Corporation
  • AccuBioTech Co. Ltd.
  • Molbio Diagnostics Pvt. Ltd.
  • Cipla Limited
  • LumiraDx
  • Alpha Laboratories
  • Anbio Biotechnology
  • Boditech Med Inc.
  • Sysmex Corporation
  • Terumo Corporation
  • MicroPort
  • Sinocare
  • Mindray Medical International Limited
  • Trivitron Healthcare
  • Biosino Bio-technology and Science Inc.
  • QuantuMDx Group Ltd.
  • EKF Diagnostics Holdings plc.
  • Qiagen N.V.
  • Biocartis Group NV
  • bioMérieux SA
  • Trinity Biotech
  • Curiosity Diagnostics
  • Bio-Rad Laboratories Inc.
  • Nexus Dx Inc.
  • Nano-Ditech Corporation
  • Medtronic plc.
  • A. Menarini Diagnostics
  • Sight Diagnostics Inc.
  • Beckman Coulter Inc. (Danaher Corporation)
  • OMNI
  • ECO Diagnóstica
  • PixCell Medical
  • Al Faisaliah Medical Systems
  • Memed
  • Future Medical
  • Diagnostic Centre Limited
  • PTS Diagnostics (Patient Focus Africa)
  • IVC Diagnostics
  • Daktari Africa
  • Withings SA
  • AliveCor Inc.
  • Preventice Solutions Inc. (Boston Scientific)
  • Koninklijke Philips N.V. (Philips Cardiologs)
  • Qardio Inc.
  • HeartFlow Inc.
  • iRhythm Technologies Inc.
  • LumiraDx Ltd.
  • Huma Ltd.

      • Table Of Contents

      1Executive Summary

      1.1 POCT (Point of Care Testing) Cardiac Disease – Market Attractiveness And Macro economic Landscape

      2 Table Of Contents

      3 List Of Tables

      4 List Of Figures

      5 Report Structure

      6 Market Characteristics

      6.1 General Market Definition

      6.2 Summary

      6.3 POCT (Point of Care Testing) Cardiac Disease Market Definition And Segmentations

      6.4 Market Segmentation By Type

      6.4.1 Digital Apps (Healthcare Solutions)

      6.4.2 Small Specimen Devices

      6.5 Market Segmentation By End-User

      6.5.1 Hospitals

      6.5.2 Diagnostic Laboratories

      6.5.3 Other End-Users

      7 Major Market Trends

      7.1 Increase In Approvals Of Point-Of-Care Test That Deliver Fast Cardiac Troponin Results

      7.2 Launch Of New Point-Of-Care Tests For Heart Failure

      7.3 Advanced Point-Of-Care Testing Devices Revolutionize Health Diagnostics

      7.4 Merger And Acquisitions To Strengthen Market Position

      8 POCT (Point of Care Testing) Cardiac Disease Market – Macro-Economic Scenario

      8.1 COVID-19 Impact On The POCT (Point of Care Testing) Cardiac Disease Market

      8.2 Impact Of The War In Ukraine On The POCT (Point of Care Testing) Cardiac Disease Market

      8.3 Impact Of High Inflation On The POCT (Point of Care Testing) Cardiac Disease Market

      9 Global Market Size And Growth

      9.1 Market Size

      9.2 Historic Market Growth 2018 – 2023 Value ($ Million)

      9.2.1 Market Drivers 2018 – 2023

      9.2.2 Market Restraints 2018 – 2023

      9.3 Forecast Market Growth 2023 – 2028 2033F Value ($ Million)

      9.3.1 Market Drivers 2023 – 2028

      9.3.2 Market Restraints 2023 – 2028

      9.4 Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      9.5 Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      10 POCT (Point of Care Testing) Cardiac Disease Market Regional and Country Analysis

      10.1 Global POCT (Point of Care Testing) Cardiac Disease Market By Region Historic and Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      10.2 Global POCT (Point of Care Testing) Cardiac Disease Market By Country Historic and Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11 Asia-Pacific Market

      11.1 Summary

      11.1.1 Market Overview

      11.1.2 Region Information

      11.1.3 Market Information

      11.1.4 Background Information

      11.1.5 Government Initiatives

      11.1.6 Regulations

      11.1.7 Regulatory Bodies

      11.1.8 Major Associations

      11.1.9 Taxes Levied

      11.1.10 Corporate Tax Structure

      11.1.11 Investments

      11.1.12 Major Companies

      11.2 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.3 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.4 Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis

      11.5 China Market

      11.6 Summary

      11.6.1 Market Overview

      11.6.2 Country Information

      11.6.3 Market Information

      11.6.4 Background Information

      11.6.5 Government Initiatives

      11.6.6 Regulations

      11.6.7 Regulatory Bodies

      11.6.8 Major Associations

      11.6.9 Taxes Levied

      11.6.10 Corporate Tax Structure

      11.6.11 Investments

      11.6.12 Major Companies

      11.7 China POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.8 China POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.9 India Market

      11.10 India POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.11 India POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.12 Japan Market

      11.13 Japan POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.14 Japan POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.15 Australia Market

      11.16 Australia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.17 Australia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.18 Indonesia Market

      11.19 Indonesia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.20 Indonesia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.21 South Korea Market

      11.22 South Korea POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      11.23 South Korea POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12 Western Europe Market

      12.1 Summary

      12.1.1 Market Overview

      12.1.2 Region Information

      12.1.3 Market Information

      12.1.4 Background Information

      12.1.5 Government Initiatives

      12.1.6 Regulations

      12.1.7 Regulatory Bodies

      12.1.8 Major Associations

      12.1.9 Taxes Levied

      12.1.10 Corporate Tax Structure

      12.1.11 Investments

      12.1.12 Major Companies

      12.2 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.3 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.4 Western Europe POCT (Point Of Care Testing) Cardiac Disease Market: Country Analysis

      12.5 UK Market

      12.6 UK POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.7 UK POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.8 Germany Market

      12.9 Germany POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.10 Germany POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.11 France Market

      12.12 France POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.13 France POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.14 Italy Market

      12.15 Italy POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.16 Italy POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.17 Spain Market

      12.18 Spain POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      12.19 Spain POCT (Point Of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      13 Eastern Europe Market

      13.1 Summary

      13.1.1 Market Overview

      13.1.2 Region Information

      13.1.3 Market Information

      13.1.4 Background Information

      13.1.5 Government Initiatives

      13.1.6 Regulations

      13.1.7 Regulatory Bodies

      13.1.8 Major Associations

      13.1.9 Taxes Levied

      13.1.10 Corporate Tax Structure

      13.1.11 Investments

      13.1.12 Major Companies

      13.2 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      13.3 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      13.4 Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis

      13.5 Russia Market

      13.6 Russia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      13.7 Russia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      14 North America Market

      14.1 Summary

      14.1.1 Market Overview

      14.1.2 Region Information

      14.1.3 Market Information

      14.1.4 Background Information

      14.1.5 Government Initiatives

      14.1.6 Regulations

      14.1.7 Regulatory Bodies

      14.1.8 Major Associations

      14.1.9 Taxes Levied

      14.1.10 Corporate Tax Structure

      14.1.11 Investments

      14.1.12 Major Companies

      14.2 North America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      14.3 North America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      14.4 North America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis

      14.5 USA Market

      14.6 Summary

      14.6.1 Market Overview

      14.6.2 Country Information

      14.6.3 Market Information

      14.6.4 Background Information

      14.6.5 Government Initiatives

      14.6.6 Regulations

      14.6.7 Regulatory Bodies

      14.6.8 Major Associations

      14.6.9 Taxes Levied

      14.6.10 Corporate Tax Structure

      14.6.11 Investments

      14.6.12 Major Companies

      14.7 USA POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      14.8 USA POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      14.9 Canada Market

      14.10 Canada POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      14.11 Canada POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      15 South America Market

      15.1 Summary

      15.1.1 Market Overview

      15.1.2 Region Information

      15.1.3 Market Information

      15.1.4 Background Information

      15.1.5 Government Initiatives

      15.1.6 Regulations

      15.1.7 Regulatory Bodies

      15.1.8 Major Associations

      15.1.9 Taxes Levied

      15.1.10 Corporate Tax Structure

      15.1.11 Investments

      15.1.12 Major Companies

      15.2 South America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      15.3 South America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      15.4 South America POCT (Point of Care Testing) Cardiac Disease Market: Country Analysis

      15.5 Brazil Market

      15.6 Brazil POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      15.7 Brazil POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      16 Middle East Market

      16.1 Summary

      16.1.1 Market Overview

      16.1.2 Region Information

      16.1.3 Market Information

      16.1.4 Background Information

      16.1.5 Government Initiatives

      16.1.6 Regulations

      16.1.7 Regulatory Bodies

      16.1.8 Major Associations

      16.1.9 Taxes Levied

      16.1.10 Corporate Tax Structure

      16.1.11 Investments

      16.1.12 Major Companies

      16.2 Middle East POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      16.3 Middle East POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      17 Africa Market

      17.1 Summary

      17.1.1 Market Overview

      17.1.2 Region Information

      17.1.3 Market Information

      17.1.4 Background Information

      17.1.5 Government Initiatives

      17.1.6 Regulations

      17.1.7 Regulatory Bodies

      17.1.8 Major Associations

      17.1.9 Taxes Levied

      17.1.10 Corporate Tax Structure

      17.1.11 Investments

      17.1.12 Major Companies

      17.2 Africa POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      17.3 Africa POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      17.4 Egypt Market

      17.5 Egypt POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      17.6 Egypt POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F Value ($ Million)

      18 POCT (Point of Care Testing) Cardiac Disease Competitive Landscape and Company Profiles

      18.1 Wondfo Biotech Co. Ltd.

      18.1.1 Company Overview

      18.1.2 Products And Services

      18.1.3 Financial Overview

      18.2 Siemens Healthineers AG

      18.2.1 Company Overview

      18.2.2 Products And Services

      18.2.3 Business Strategy

      18.2.4 Financial Overview

      18.3 QuidelOrtho Corporation

      18.3.1 Company Overview

      18.3.2 Products And Services

      18.3.3 Financial Overview

      18.4 F. Hoffman-La Roche Ltd

      18.4.1 Company Overview

      18.4.2 Products And Services

      18.4.3 Business Strategy

      18.4.4 Financial Overview

      18.5 Abbott Laboratories

      18.5.1 Company Overview

      18.5.2 Products And Services

      18.5.3 Financial Overview

      18.6 OraSure Technologies Inc.

      18.6.1 Company Overview

      18.6.2 Products And Services

      18.6.3 Financial Overview

      18.7 Hologic Inc.

      18.7.1 Company Overview

      18.7.2 Products And Services

      18.7.3 Financial Overview

      18.8 Thermo Fisher Scientific Inc.

      18.8.1 Company Overview

      18.8.2 Products And Services

      18.8.3 Business Strategy

      18.8.4 Financial Overview

      18.9 SARSTEDT AG & Co. KG

      18.9.1 Company Overview

      18.9.2 Products And Services

      18.9.3 Financial Overview

      18.10 Nova Biomedical Corporation

      18.10.1 Company Overview

      18.10.2 Products And Services

      18.10.3 Financial Overview

      19 Digital App (Healthcare Solution) Competitive Landscape and Company Profiles

      19.1 Digital App (Healthcare Solution) Market Company Profiles

      19.2 QuidelOrtho Corporation

      19.2.1 Company Overview

      19.2.2 Products And Services

      19.2.3 Financial Overview

      19.3 Withings SA

      19.3.1 Company Overview

      19.3.2 Products And Services

      19.3.3 Financial Overview

      19.4 AliveCor Inc.

      19.4.1 Company Overview

      19.4.2 Products And Services

      19.4.3 Business Strategy

      19.4.4 Financial Overview

      19.5 Preventice Solutions Inc. (Boston Scientific)

      19.5.1 Company Overview

      19.5.2 Products And Services

      19.5.3 Financial Overview

      19.6 Koninklijke Philips N.V. (Philips Cardiologs)

      19.6.1 Company Overview

      19.6.2 Products And Services

      19.6.3 Business Strategy

      19.6.4 Financial Overview

      19.7 Qardio Inc.

      19.7.1 Company Overview

      19.7.2 Products And Services

      19.7.3 Financial Overview

      19.8 HeartFlow Inc.

      19.8.1 Company Overview

      19.8.2 Products And Services

      19.8.3 Business Strategy

      19.8.4 Financial Overview

      19.9 iRhythm Technologies Inc.

      19.9.1 Company Overview

      19.9.2 Products And Services

      19.9.3 Financial Overview

      19.10 LumiraDx Ltd.

      19.10.1 Company Overview

      19.10.2 Products And Services

      19.10.3 Financial Overview

      19.11 Huma Ltd.

      19.11.1 Company Overview

      19.11.2 Products And Services

      19.11.3 Business Strategy

      19.11.4 Financial Overview

      20 Small Specimen Devices Competitive Landscape and Company Profiles

      20.1 Small Specimen Devices Market Company Profiles

      20.2 Wondfo Biotech Co. Ltd.

      20.2.1 Company Overview

      20.2.2 Products And Services

      20.2.3 Financial Overview

      20.3 Siemens Healthineers AG

      20.3.1 Company Overview

      20.3.2 Products And Services

      20.3.3 Financial Overview

      20.4 F. Hoffman-La Roche Ltd

      20.4.1 Company Overview

      20.4.2 Products And Services

      20.4.3 Financial Overview

      20.5 QuidelOrtho Corporation

      20.5.1 Company Overview

      20.5.2 Products And Services

      20.5.3 Financial Overview

      20.6 OraSure Technologies Inc.

      20.6.1 Company Overview

      20.6.2 Products And Services

      20.6.3 Financial Overview

      20.7 Hologic Inc.

      20.7.1 Company Overview

      20.7.2 Products And Services

      20.7.3 Financial Overview

      20.8 Abbott Laboratories

      20.8.1 Company Overview

      20.8.2 Products And Services

      20.8.3 Financial Overview

      20.9 Thermo Fisher Scientific Inc.

      20.9.1 Company Overview

      20.9.2 Products And Services

      20.9.3 Business Strategy

      20.9.4 Financial Overview

      20.10 SARSTEDT AG & Co. KG

      20.10.1 Company Overview

      20.10.2 Products And Services

      20.10.3 Financial Overview

      20.11 Nova Biomedical Corporation

      20.11.1 Company Overview

      20.11.2 Products And Services

      20.11.3 Financial Overview

      21 Key Mergers And Acquisitions

      21.1 Roche Holding AG Acquired LumiraDx

      21.2 SD Biosensor Inc And SJL Partners Acquired Meridian Bioscience Inc

      21.3 Shineco Inc Acquired Changzhou Biowin Pharmaceutical Co

      21.4 Bio-Rad Laboratories Inc Acquired Curiosity Diagnostics

      21.5 Roche Holding AG Acquired GenMark Diagnostics

      22 Opportunities And Strategies

      22.1 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 – Countries Offering Most New Opportunities

      22.2 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 – Segments Offering Most New Opportunities

      22.3 Global POCT (Point of Care Testing) Cardiac Disease Market In 2028 – Growth Strategies

      22.3.1 Market Trend Based Strategies

      22.3.2 Competitor Strategies

      23 POCT (Point of Care Testing) Cardiac Disease Market Conclusions And Recommendations

      23.1 Conclusions

      23.2 Recommendations

      23.2.1 Product

      23.2.2 Place

      23.2.3 Price

      23.2.4 Promotion

      23.2.5 People

      24 Appendix

      24.1 Geographies Covered

      24.2 Market Data Sources

      24.3 Research Methodology

      24.4 Currencies

      24.5 The Business Research Company

      24.6 Copyright and Disclaimer

    List Of Tables

      Table 1: Global POCT (Point of Care Testing) Cardiac Disease Market Historic 2018 – 2023 $ Million
    • Table 2: Global POCT (Point of Care Testing) Cardiac Disease Market Forecast 2023 – 2028 2033F $ Million
    • Table 3: Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 4: Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 5: Global POCT (Point of Care Testing) Cardiac Disease Market By Region Historic and Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 6: Global POCT (Point of Care Testing) Cardiac Disease Market By Country Historic and Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 7: Asia-Pacific GDP Per Capita By Country 2018-2023 $
    • Table 8:  Asia-Pacific Population By Country 2018-2028 Millions
    • Table 9: Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 10: Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 11: China GDP Per Capita 2018-2023 $
    • Table 12:  China Population 2018-2028 Millions
    • Table 13: China POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 14: China POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 15: India POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 16: India POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 17: Japan POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 18: Japan POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 19: Australia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 20: Australia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 21: Indonesia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 22: Indonesia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 23: South Korea POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 24: South Korea POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 25: Western Europe GDP Per Capita By Country 2018-2023 $
    • Table 26:  Western Europe Population By Country 2018-2028 Millions
    • Table 27: Western Europe POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 28: Western Europe POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 29: UK POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 30: UK POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 31: Germany POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 32: Germany POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 33: France POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 34: France POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 35: Italy POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 36: Italy POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 37: Spain POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 38: Spain POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 39: Eastern Europe GDP Per Capita By Country 2018-2023 $
    • Table 40:  Eastern Europe Population By Country 2018-2028 Millions
    • Table 41: Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 42: Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 43: Russia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 44: Russia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 45: North America GDP Per Capita By Country 2018-2023 $
    • Table 46:  North America Population By Country 2018-2028 Millions
    • Table 47: North America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 48: North America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 49: USA GDP Per Capita 2018-2023 $
    • Table 50:  USA Population 2018-2028 Millions
    • Table 51: USA POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 52: USA POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 53: Canada POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 54: Canada POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 55: South America GDP Per Capita By Country 2018-2023 $
    • Table 56:  South America Population By Country 2018-2028 Millions
    • Table 57: South America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 58: South America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 59: Brazil POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 60: Brazil POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 61: Middle East GDP Per Capita By Country 2018-2023 $
    • Table 62:  Middle East Population By Country 2018-2028 Millions
    • Table 63: Middle East POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 64: Middle East POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 65: Africa GDP Per Capita By Country 2018-2023 $
    • Table 66:  Africa Population By Country 2018-2028 Millions
    • Table 67: Africa POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 68: Africa POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 69: Egypt POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 70: Egypt POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Table 71: Global POCT (Point of Care Testing) Cardiac Disease Market Key Competitor Estimated Market Shares 2023 Percentage (%)
    • Table 72: Wondfo Biotech Co. Ltd. – Financial Overview 2023 $Million
    • Table 73: Siemens Healthineers AG – Financial Overview 2019 – 2023 $Billion
    • Table 74: QuidelOrtho Corporation – Financial Overview 2019 – 2023 $ Billion
    • Table 75: F. Hoffman-La Roche Ltd – Financial Overview 2019 – 2023 $ Billion
    • Table 76: Abbott Laboratories – Financial Overview 2019 – 2023 $Billion
    • Table 77: OraSure Technologies Inc. – Financial Overview 2023 $Million
    • Table 78: Hologic Inc. – Financial Overview 2019 – 2023 $Billion
    • Table 79: Thermo Fisher Scientific Inc. – Financial Overview 2019 – 2023 $Billion
    • Table 80: SARSTEDT AG & Co. KG – Financial Overview 2023 $Million
    • Table 81: Nova Biomedical Corporation – Financial Overview 2023 $Million
    • Table 82: Global Digital App (Healthcare Solution) Market Key Competitor Estimated Market Shares 2023 Percentage (%)
    • Table 83: QuidelOrtho Corporation – Financial Overview 2020 – 2023 $Billion
    • Table 84: Withings SA – Financial Overview 2023 $ Million
    • Table 85: AliveCor Inc. – Financial Overview 2023 $ Million
    • Table 86: Preventice Solutions Inc. (Boston Scientific) – Financial Overview 2019 – 2023 $Billion
    • Table 87: Koninklijke Philips N.V. (Philips Cardiologs) – Financial Overview 2019 – 2023 $Billion
    • Table 88: Qardio Inc. – Financial Overview 2023 $ Million
    • Table 89: HeartFlow Inc. – Financial Overview 2023 $ Million
    • Table 90: iRhythm Technologies Inc. – Financial Overview 2019 – 2023 $Billion
    • Table 91: LumiraDx Ltd. – Financial Overview 2023 $ Million
    • Table 92: Huma Ltd. – Financial Overview 2023 $ Million
    • Table 93: Global Small Specimen Devices Market Key Competitor Estimated Market Shares 2023 Percentage (%)
    • Table 94: Wondfo Biotech Co. Ltd. – Financial Overview 2023 $Million
    • Table 95: Siemens Healthineers AG – Financial Overview 2019 – 2023 $Billion
    • Table 96: F. Hoffman-La Roche Ltd – Financial Overview 2019 – 2023 $ Billion
    • Table 97: QuidelOrtho Corporation – Financial Overview 2019 – 2023 $ Billion
    • Table 98: OraSure Technologies Inc. – Financial Overview 2023 $Million
    • Table 99: Hologic Inc. – Financial Overview 2019 – 2023 $Billion
    • Table 100: Abbott Laboratories – Financial Overview 2019 – 2023 $Billion
    • Table 101: Thermo Fisher Scientific Inc. – Financial Overview 2019 – 2023 $Billion
    • Table 102: SARSTEDT AG & Co. KG – Financial Overview 2023 $Million
    • Table 103: Nova Biomedical Corporation – Financial Overview 2023 $Million
    • Table 104: Global POCT (Point of Care Testing) Cardiac Disease Market Size Gain ($ Million) 2023 – 2028 By Country
    • Table 105: Global POCT (Point of Care Testing) Cardiac Disease Market Size Gain ($ Million) Segmentation By Type 2023 – 2028
    • Table 106: Global POCT (Point of Care Testing) Cardiac Disease Market Size Gain ($ Million) Segmentation By End User 2023 – 2028
    • Table 107: POCT (Point of Care Testing) Cardiac Disease Market Data Sources

    List Of Figures

      Figure 1: Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type
    • Figure 2: Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End-User
    • Figure 3: Global POCT (Point of Care Testing) Cardiac Disease Market Historic 2018 – 2023 $ Million
    • Figure 4: Global POCT (Point of Care Testing) Cardiac Disease Market Forecast 2023 – 2028 2033F $ Million
    • Figure 5: Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 6: Global POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 7: Global POCT (Point of Care Testing) Cardiac Disease Market By Region Historic and Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 8: Global POCT (Point of Care Testing) Cardiac Disease Market By Country Historic and Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 9: Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 10: Asia-Pacific POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 11: China POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 12: China POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 13: India POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 14: India POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 15: Japan POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 16: Japan POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 17: Australia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 18: Australia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 19: Indonesia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 20: Indonesia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 21: South Korea POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 22: South Korea POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 23: Western Europe POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 24: Western Europe POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 25: UK POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 26: UK POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 27: Germany POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 28: Germany POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 29: France POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 30: France POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 31: Italy POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 32: Italy POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 33: Spain POCT (point of care testing) cardiac disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 34: Spain POCT (point of care testing) cardiac disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 35: Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 36: Eastern Europe POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 37: Russia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 38: Russia POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 39: North America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 40: North America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 41: USA POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 42: USA POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 43: Canada POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 44: Canada POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 45: South America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 46: South America POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 47: Brazil POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 48: Brazil POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 49: Middle East POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 50: Middle East POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 51: Africa POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 52: Africa POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 53: Egypt POCT (Point of Care Testing) Cardiac Disease Market Segmentation By Type Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 54: Egypt POCT (Point of Care Testing) Cardiac Disease Market Segmentation By End User Historic And Forecast 2018 – 2023 2028F 2033F $ Million
    • Figure 55: Global POCT (Point of Care Testing) Cardiac Disease Market Key Competitor Estimated Market Shares 2023 Percentage (%)
    • Figure 56: Siemens Healthineers AG – Financial Overview 2019 – 2023 $ Billion
    • Figure 57: QuidelOrtho Corporation – Financial Overview 2019 – 2023 $ Billion
    • Figure 58: F. Hoffman-La Roche Ltd – Financial Overview 2019 – 2023 $ Billion
    • Figure 59: Abbott Laboratories – Financial Overview 2019 – 2023 $ Billion
    • Figure 60: Hologic Inc. – Financial Overview 2019 – 2023 $ Billion
    • Figure 61: Thermo Fisher Scientific Inc. – Financial Overview 2019 – 2023 $ Billion
    • Figure 62: Global Digital App (Healthcare Solution) Market Key Competitor Estimated Market Shares 2023 Percentage (%)
    • Figure 63: QuidelOrtho Corporation – Financial Overview 2020 – 2023 $ Billion
    • Figure 64: Preventice Solutions Inc. (Boston Scientific) – Financial Overview 2019 – 2023 $ Billion
    • Figure 65: Koninklijke Philips N.V. (Philips Cardiologs) – Financial Overview 2019 – 2023 $ Billion
    • Figure 66: iRhythm Technologies Inc. – Financial Overview 2019 – 2023 $ Billion
    • Figure 67: Global Small Specimen Devices Market Key Competitor Estimated Market Shares 2023 Percentage (%)
    • Figure 68: Siemens Healthineers AG – Financial Overview 2019 – 2023 $ Billion
    • Figure 69: F. Hoffman-La Roche Ltd – Financial Overview 2019 – 2023 $ Billion
    • Figure 70: QuidelOrtho Corporation – Financial Overview 2019 – 2023 $ Billion
    • Figure 71: Hologic Inc. – Financial Overview 2019 – 2023 $ Billion
    • Figure 72: Abbott Laboratories – Financial Overview 2019 – 2023 $ Billion
    • Figure 73: Thermo Fisher Scientific Inc. – Financial Overview 2019 – 2023 $ Billion
    • Figure 74: Geographic Regions Covered

    Global Anesthesia Machines Market 2022 – Market Opportunities And Strategies

    Read More

    Latest Benign Prostatic Hyperplasia BPH Treatment Devices And Equipment Market Growth Study 2022-2026 By The Business Research Company

    Read More

    What Is The Computed Tomography CT Scanners Devices And Equipment Market Overview In 2022?

    Read More

    How Will The Laryngoscope Market Grow In 2022?

    Read More

    The Business Research Company offers the surgical retractors market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the topical drug delivery market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the single-use assemblies market research report 2022 with industry size, share, segments and market growth

    Read More

    The Business Research Company offers the neuroscience antibodies and assays market research report 2022 with industry size, share, segments and market growth

    Read More

    Dialysis Devices And Equipment Market 2021 - By Product (Hemodialysis Devices, Peritoneal Dialysis Devices, Continuous Renal Replacement Therapy (CRRT) Systems, Consumables), By End-User (Hospitals And Clinics, Ambulatory Surgical Centers, Homecare Settings), By Application (Serum And Blood Treatment, Virus Purification, Drug Binding Studies), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Joint Reconstruction Devices And Equipment Market 2021 - By Type (Knee Reconstruction Devices, Hip Reconstruction Devices, Extremity Reconstruction Devices), By Application (Arthrodesis, Arthroscopy, Joint Replacement Surgery, Osteotomy, Resurfacing Surgery, Small Joint Surgery), By End User (Hospitals, Orthopedic Clinics, Ambulatory Surgical Centers), And By Region, Opportunities And Strategies – Global Forecast To 2030

    View Report

    Radiotherapy Devices Global Market Report 2024 – By Product Type (External Beam Radiation Therapy Devices, Linear Accelerator Devices, Proton Therapy Devices), By Application (Skin Cancer, Breast Cancer, Prostate Cancer, Cervical Cancer, Lung Cancer, Other Applications), By End Users (Hospitals, Ambulatory Surgical Centers, Oncological Treatment Centers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Tumor Ablation Therapy Devices Global Market Report 2024 – By Technology (Radiofrequency Ablation, Microwave Ablation, Cryoablation, Irreversible Electroporation Ablation, Other Technologies), By Treatment (Surgical, Laparoscopic, Percutaneous), By Application (Kidney Cancer, Liver Cancer, Breast Cancer, Lung Cancer, Prostate Cancer, Other Applications), By End User (Hospitals, Oncology Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Oncology Devices Global Market Report 2024 – By Device Type (Brachytherapy Devices, Endoscopic Devices), By Therapy (Chemotherapy, Hormone Therapy, Biotherapy/Immunotherapy, Radiation Therapy), By End User (Hospitals, Cancer Research Institutes, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Tumor Embolization Devices Global Market Report 2024 – By Type (Radioembolic Agents, Non-radioactive Embolic Agents), By Application (Cancer Tumors, Noncancerous Tumors), By End User (Hospitals, Cancer Treatment Centers, Intensive Care Units, Surgical Centers) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Liposomal Drug Delivery Devices Global Market Report 2024 – By Type (Liposomal Doxorubicin, Liposomal Paclitaxel, Liposomal Amphotericin B, Other Types), By Application (Fungal Diseases, Cancer Therapy, Pain Management, Viral Vaccines, Photodynamic Therapy), By End User (Hospitals, Diagnostic Centers, Ambulatory Surgery Centers/Clinics, Other End Users) – Market Size, Trends, And Global Forecast 2024-2033

    View Report

    Gastrointestinal Devices Global Market Report 2024 – By Product Type (GI Videoscopes, Biopsy Devices, Endoscopic Retrograde Cholangiopancreatography Devices (ERCP), Capsule Endoscopy, Endoscopic Ultrasound, Endoscopic Mucosal Resection (EMR), Hemostasis Devices, Other Product Types), By Sales Channel (Online Retailing, Medical Stores & Brand Outlet), By End Users (Hospitals, Clinics & Dialysis Centers, Ambulatory Surgical Center) – Market Size, Trends, And Global Forecast 2024-2033

    View Report